The importance of a shared definition of left ventricular hypertrophy: The case of obese women

Luca Alessandro Gondoni, Anna Maria Titon, Mariella Montano, Ferruccio Nibbio, Gianandrea Bertone

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background Left ventricular hypertrophy (LVH) is a risk factor for all-cause mortality. Left ventricular (LV) mass is usually indexed for normalizing the value to the patients phenotype and a correction by body surface area (BSA) is widely utilized being the only approved one according to the last echocardiography guidelines. However indexing LV mass by BSA may cause an underestimation of LVH prevalence in obese subjects and many authors have utilized in the obese subset of patients a correction by height2.7. The aim of our study was to quantify the number of obese patients who, despite having an increased LV mass, fall in the range of normality because they do not reach the LVH cutoff according to the new guidelines. Methods We reviewed the echocardiograms of 384 white women free from cardiovascular disease. Ninety-six patients (25%) were obese: among them 42 had mild obesity and 54 had moderate or severe obesity. Results In the obese group, the prevalence of LVH using the absolute LV mass value was similar to the one obtained with the height2.7 correction while a significant smaller number of patients had LVH according to BSA correction. Our study confirms that the method used for correcting LV mass significantly influences the diagnosis of LVH in a non-selected female population: using body surface area underestimates the prevalence of LVH as compared to allometric measures in the obese subset of patients. Conclusion We recommend that height2.7 be used for LV mass correction in obese patients.

Original languageEnglish
Pages (from-to)404-406
Number of pages3
JournalInternational Journal of Cardiology
Volume227
DOIs
Publication statusPublished - Jan 15 2017

Fingerprint

Left Ventricular Hypertrophy
Body Surface Area
Guidelines
Morbid Obesity
Echocardiography
Cardiovascular Diseases
Obesity
Phenotype
Mortality
Population

Keywords

  • Echocardiography
  • Left ventricular hypertrophy
  • Obesity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The importance of a shared definition of left ventricular hypertrophy : The case of obese women. / Alessandro Gondoni, Luca; Titon, Anna Maria; Montano, Mariella; Nibbio, Ferruccio; Bertone, Gianandrea.

In: International Journal of Cardiology, Vol. 227, 15.01.2017, p. 404-406.

Research output: Contribution to journalArticle

Alessandro Gondoni, Luca ; Titon, Anna Maria ; Montano, Mariella ; Nibbio, Ferruccio ; Bertone, Gianandrea. / The importance of a shared definition of left ventricular hypertrophy : The case of obese women. In: International Journal of Cardiology. 2017 ; Vol. 227. pp. 404-406.
@article{0a2ada40bdbb46f3991284310585fc29,
title = "The importance of a shared definition of left ventricular hypertrophy: The case of obese women",
abstract = "Background Left ventricular hypertrophy (LVH) is a risk factor for all-cause mortality. Left ventricular (LV) mass is usually indexed for normalizing the value to the patients phenotype and a correction by body surface area (BSA) is widely utilized being the only approved one according to the last echocardiography guidelines. However indexing LV mass by BSA may cause an underestimation of LVH prevalence in obese subjects and many authors have utilized in the obese subset of patients a correction by height2.7. The aim of our study was to quantify the number of obese patients who, despite having an increased LV mass, fall in the range of normality because they do not reach the LVH cutoff according to the new guidelines. Methods We reviewed the echocardiograms of 384 white women free from cardiovascular disease. Ninety-six patients (25{\%}) were obese: among them 42 had mild obesity and 54 had moderate or severe obesity. Results In the obese group, the prevalence of LVH using the absolute LV mass value was similar to the one obtained with the height2.7 correction while a significant smaller number of patients had LVH according to BSA correction. Our study confirms that the method used for correcting LV mass significantly influences the diagnosis of LVH in a non-selected female population: using body surface area underestimates the prevalence of LVH as compared to allometric measures in the obese subset of patients. Conclusion We recommend that height2.7 be used for LV mass correction in obese patients.",
keywords = "Echocardiography, Left ventricular hypertrophy, Obesity",
author = "{Alessandro Gondoni}, Luca and Titon, {Anna Maria} and Mariella Montano and Ferruccio Nibbio and Gianandrea Bertone",
year = "2017",
month = "1",
day = "15",
doi = "10.1016/j.ijcard.2016.11.032",
language = "English",
volume = "227",
pages = "404--406",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - The importance of a shared definition of left ventricular hypertrophy

T2 - The case of obese women

AU - Alessandro Gondoni, Luca

AU - Titon, Anna Maria

AU - Montano, Mariella

AU - Nibbio, Ferruccio

AU - Bertone, Gianandrea

PY - 2017/1/15

Y1 - 2017/1/15

N2 - Background Left ventricular hypertrophy (LVH) is a risk factor for all-cause mortality. Left ventricular (LV) mass is usually indexed for normalizing the value to the patients phenotype and a correction by body surface area (BSA) is widely utilized being the only approved one according to the last echocardiography guidelines. However indexing LV mass by BSA may cause an underestimation of LVH prevalence in obese subjects and many authors have utilized in the obese subset of patients a correction by height2.7. The aim of our study was to quantify the number of obese patients who, despite having an increased LV mass, fall in the range of normality because they do not reach the LVH cutoff according to the new guidelines. Methods We reviewed the echocardiograms of 384 white women free from cardiovascular disease. Ninety-six patients (25%) were obese: among them 42 had mild obesity and 54 had moderate or severe obesity. Results In the obese group, the prevalence of LVH using the absolute LV mass value was similar to the one obtained with the height2.7 correction while a significant smaller number of patients had LVH according to BSA correction. Our study confirms that the method used for correcting LV mass significantly influences the diagnosis of LVH in a non-selected female population: using body surface area underestimates the prevalence of LVH as compared to allometric measures in the obese subset of patients. Conclusion We recommend that height2.7 be used for LV mass correction in obese patients.

AB - Background Left ventricular hypertrophy (LVH) is a risk factor for all-cause mortality. Left ventricular (LV) mass is usually indexed for normalizing the value to the patients phenotype and a correction by body surface area (BSA) is widely utilized being the only approved one according to the last echocardiography guidelines. However indexing LV mass by BSA may cause an underestimation of LVH prevalence in obese subjects and many authors have utilized in the obese subset of patients a correction by height2.7. The aim of our study was to quantify the number of obese patients who, despite having an increased LV mass, fall in the range of normality because they do not reach the LVH cutoff according to the new guidelines. Methods We reviewed the echocardiograms of 384 white women free from cardiovascular disease. Ninety-six patients (25%) were obese: among them 42 had mild obesity and 54 had moderate or severe obesity. Results In the obese group, the prevalence of LVH using the absolute LV mass value was similar to the one obtained with the height2.7 correction while a significant smaller number of patients had LVH according to BSA correction. Our study confirms that the method used for correcting LV mass significantly influences the diagnosis of LVH in a non-selected female population: using body surface area underestimates the prevalence of LVH as compared to allometric measures in the obese subset of patients. Conclusion We recommend that height2.7 be used for LV mass correction in obese patients.

KW - Echocardiography

KW - Left ventricular hypertrophy

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=85004064476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85004064476&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2016.11.032

DO - 10.1016/j.ijcard.2016.11.032

M3 - Article

C2 - 27856041

AN - SCOPUS:85004064476

VL - 227

SP - 404

EP - 406

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -